Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	UDP-galactose transmembrane transporter activity	SLC35A3 SLC35A2	6.56e-05	3	94	2	GO:0005459
GeneOntologyMolecularFunction	CDP phosphatase activity	ENTPD6 ENTPD5	1.31e-04	4	94	2	GO:0036384
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	CACNA1C CACNA1D	2.17e-04	5	94	2	GO:0086007
GeneOntologyMolecularFunction	IDP phosphatase activity	ENTPD6 ENTPD5	2.17e-04	5	94	2	GO:1990003
GeneOntologyMolecularFunction	splicing factor binding	SF3B4 SF3B1	4.53e-04	7	94	2	GO:1990935
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC6A4 SLC35A3 SLC35A2 SLC9A7 SLC17A8 SLCO3A1 SLC39A8	4.99e-04	296	94	7	GO:0015291
GeneOntologyMolecularFunction	UDP phosphatase activity	ENTPD6 ENTPD5	7.73e-04	9	94	2	GO:0045134
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO2 NOMO3 NOMO1	7.55e-06	9	94	3	GO:0160063
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO3 NOMO1	7.02e-06	9	93	3	GO:0160064
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO2 NOMO3 NOMO1	2.99e-05	14	93	3	GO:0072379
Domain	DUF2012	NOMO2 NOMO3 NOMO1	4.17e-07	4	89	3	PF09430
Domain	DUF2012	NOMO2 NOMO3 NOMO1	4.17e-07	4	89	3	IPR019008
Domain	Carb-bd-like_fold	NOMO2 NOMO3 NOMO1	5.76e-06	8	89	3	IPR013784
Domain	CarboxyPept_regulatory_dom	NOMO2 NOMO3 NOMO1	2.89e-05	13	89	3	IPR014766
Domain	-	NOMO2 NOMO3 NOMO1	2.89e-05	13	89	3	2.60.40.1120
Domain	CAC1F_C	CACNA1C CACNA1D	6.72e-05	3	89	2	IPR031688
Domain	CAC1F_C	CACNA1C CACNA1D	6.72e-05	3	89	2	PF16885
Domain	CarboxyPept-like_regulatory	NOMO2 NOMO3 NOMO1	6.78e-05	17	89	3	IPR008969
Domain	VDCC_L_a1su	CACNA1C CACNA1D	1.34e-04	4	89	2	IPR005446
Domain	Nuc_sug_transpt	SLC35A3 SLC35A2	2.22e-04	5	89	2	IPR007271
Domain	Nuc_sug_transp	SLC35A3 SLC35A2	2.22e-04	5	89	2	PF04142
Domain	VDCC_a1su_IQ	CACNA1C CACNA1D	4.64e-04	7	89	2	IPR014873
Domain	GPHH	CACNA1C CACNA1D	4.64e-04	7	89	2	PF16905
Domain	GPHH_dom	CACNA1C CACNA1D	4.64e-04	7	89	2	IPR031649
Domain	Ca_chan_IQ	CACNA1C CACNA1D	4.64e-04	7	89	2	SM01062
Domain	Ca_chan_IQ	CACNA1C CACNA1D	4.64e-04	7	89	2	PF08763
Domain	Calx_beta	FREM3 ITGB4	6.17e-04	8	89	2	SM00237
Domain	FLAVODOXIN_LIKE	NDOR1 TYW1	6.17e-04	8	89	2	PS50902
Domain	GDA1_CD39_NTPase	ENTPD6 ENTPD5	6.17e-04	8	89	2	IPR000407
Domain	Flavodoxin/NO_synth	NDOR1 TYW1	6.17e-04	8	89	2	IPR008254
Domain	GDA1_CD39	ENTPD6 ENTPD5	6.17e-04	8	89	2	PF01150
Domain	Flavdoxin-like	NDOR1 TYW1	6.17e-04	8	89	2	IPR001094
Domain	Flavodoxin_1	NDOR1 TYW1	6.17e-04	8	89	2	PF00258
Domain	GDA1_CD39_NTPASE	ENTPD6 ENTPD5	6.17e-04	8	89	2	PS01238
Domain	Calx_beta	FREM3 ITGB4	7.91e-04	9	89	2	IPR003644
Domain	Calx-beta	FREM3 ITGB4	7.91e-04	9	89	2	PF03160
Domain	-	HHIP APMAP TRIM3	8.44e-04	39	89	3	2.120.10.30
Domain	IG_FLMN	POGLUT3 TRIM3	9.86e-04	10	89	2	SM00557
Domain	Flavoprotein-like_dom	NDOR1 TYW1	9.86e-04	10	89	2	IPR029039
Domain	VDCCAlpha1	CACNA1C CACNA1D	9.86e-04	10	89	2	IPR002077
Domain	-	NDOR1 TYW1	9.86e-04	10	89	2	3.40.50.360
Domain	Filamin	POGLUT3 TRIM3	1.20e-03	11	89	2	PF00630
Domain	FILAMIN_REPEAT	POGLUT3 TRIM3	1.20e-03	11	89	2	PS50194
Domain	Filamin/ABP280_rpt	POGLUT3 TRIM3	1.20e-03	11	89	2	IPR001298
Domain	Filamin/ABP280_repeat-like	POGLUT3 TRIM3	1.20e-03	11	89	2	IPR017868
Domain	-	POGLUT3 PDGFRL BTNL8 NOMO2 EXOC2 PLXNB2 ITGB4 TRIM3 NOMO3 NOMO1	1.21e-03	663	89	10	2.60.40.10
Domain	6-blade_b-propeller_TolB-like	HHIP APMAP TRIM3	1.37e-03	46	89	3	IPR011042
Domain	Ig_E-set	POGLUT3 EXOC2 PLXNB2 TRIM3	1.54e-03	104	89	4	IPR014756
Domain	Ig-like_fold	POGLUT3 PDGFRL BTNL8 NOMO2 EXOC2 PLXNB2 ITGB4 TRIM3 NOMO3 NOMO1	1.93e-03	706	89	10	IPR013783
Domain	Ion_trans_dom	CACNA1C CACNA1D KCNU1 TRPA1	2.16e-03	114	89	4	IPR005821
Domain	Ion_trans	CACNA1C CACNA1D KCNU1 TRPA1	2.16e-03	114	89	4	PF00520
Domain	-	ANTXR1 ITGB4 ITIH4	5.31e-03	74	89	3	3.40.50.410
Domain	EF-hand_5	NECAB1 MICU1	6.27e-03	25	89	2	PF13202
Domain	VWFA	ANTXR1 ITGB4 ITIH4	7.06e-03	82	89	3	PS50234
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO3 NOMO1	1.91e-08	3	94	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO3 NOMO1	1.91e-08	3	94	3	25576386
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO3 NOMO1	7.63e-08	4	94	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO3 NOMO1	7.63e-08	4	94	3	9267806
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DNAJB12 CACNA1C SNX30 SLC35A3 THOP1 TTLL3 PLPP1 SH3TC1 ZNF875 APMAP SLC9A7 ANTXR1 SAMM50 MCCC2 CSMD1 PLEKHM1 SIL1 MICU1	8.61e-08	1489	94	18	28611215
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PIGN DNAJB12 HSP90B1 MIA2 MGST3 NOMO2 GNPTAB ENTPD6 SLC35A2 EDEM2 ANTXR1 TYW1 PLXNB2 ITGB4 SIL1 NOMO1	1.35e-07	1201	94	16	35696571
Pubmed	PTIP chromatin regulator controls development and activation of B cell subsets to license humoral immunity in mice.	RAG1 NDOR1 TP53BP1	3.80e-07	6	94	3	29078319
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO2 NOMO3 NOMO1	1.06e-06	8	94	3	15257293
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	HSP90B1 NOMO2 NOMO3 NOMO1	1.49e-06	31	94	4	19136429
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO2 NOMO3 NOMO1	1.59e-06	9	94	3	36261522
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO2 NOMO3 NOMO1	3.11e-06	11	94	3	32820719
Pubmed	Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.	CACNA1D KCNU1 CSMD1	4.13e-06	12	94	3	21901158
Pubmed	Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity.	RAG1 TOB1	7.23e-06	2	94	2	23797093
Pubmed	Different roles attributed to Cav1 channel subtypes in spontaneous action potential firing and fine tuning of exocytosis in mouse chromaffin cells.	CACNA1C CACNA1D	7.23e-06	2	94	2	21054386
Pubmed	UDP-Gal/UDP-GlcNAc chimeric transporter complements mutation defect in mammalian cells deficient in UDP-Gal transporter.	SLC35A3 SLC35A2	7.23e-06	2	94	2	23583405
Pubmed	An improved targeted cAMP sensor to study the regulation of adenylyl cyclase 8 by Ca2+ entry through voltage-gated channels.	CACNA1C CACNA1D	7.23e-06	2	94	2	24086669
Pubmed	Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.	CACNA1C CACNA1D	7.23e-06	2	94	2	26049024
Pubmed	Genetic polymorphisms of L-type calcium channel alpha1C and alpha1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers.	CACNA1C CACNA1D	7.23e-06	2	94	2	19225208
Pubmed	Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB.	CACNA1C CACNA1D	7.23e-06	2	94	2	16706838
Pubmed	Temperature-sensitive Cav1.2 calcium channels support intrinsic firing of pyramidal neurons and provide a target for the treatment of febrile seizures.	CACNA1C CACNA1D	7.23e-06	2	94	2	23761887
Pubmed	Non-voltage-gated L-type Ca2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits.	CACNA1C CACNA1D	7.23e-06	2	94	2	14981074
Pubmed	CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum.	CACNA1C CACNA1D	7.23e-06	2	94	2	25292336
Pubmed	Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle.	CACNA1C CACNA1D	7.23e-06	2	94	2	17526649
Pubmed	Ligand-activated signal transduction in the 2-cell embryo.	CACNA1C CACNA1D	7.23e-06	2	94	2	12606379
Pubmed	Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators.	CACNA1C CACNA1D	7.23e-06	2	94	2	24941892
Pubmed	Equal sensitivity of Cav1.2 and Cav1.3 channels to the opposing modulations of PKA and PKG in mouse chromaffin cells.	CACNA1C CACNA1D	7.23e-06	2	94	2	22826131
Pubmed	Transcriptional regulation of L-type calcium channel subtypes Cav1.2 and Cav1.3 by nicotine and their potential role in nicotine sensitization.	CACNA1C CACNA1D	7.23e-06	2	94	2	24470632
Pubmed	Cav1.2 and Cav1.3 L-type calcium channels operate in a similar voltage range but show different coupling to Ca(2+)-dependent conductances in hippocampal neurons.	CACNA1C CACNA1D	7.23e-06	2	94	2	24760982
Pubmed	Deletion of the L-type calcium channel Ca(V) 1.3 but not Ca(V) 1.2 results in a diminished sAHP in mouse CA1 pyramidal neurons.	CACNA1C CACNA1D	7.23e-06	2	94	2	20014384
Pubmed	Role of putative voltage-sensor countercharge D4 in regulating gating properties of CaV1.2 and CaV1.3 calcium channels.	CACNA1C CACNA1D	7.23e-06	2	94	2	30001160
Pubmed	Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice.	CACNA1C CACNA1D	7.23e-06	2	94	2	21352396
Pubmed	Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells.	CACNA1C CACNA1D	7.23e-06	2	94	2	17409250
Pubmed	Neuronal L-type calcium channels open quickly and are inhibited slowly.	CACNA1C CACNA1D	7.23e-06	2	94	2	16267232
Pubmed	The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.	CACNA1C CACNA1D	7.23e-06	2	94	2	24996399
Pubmed	Genetic, cellular, and functional evidence for Ca2+ inflow through Cav1.2 and Cav1.3 channels in murine spiral ganglion neurons.	CACNA1C CACNA1D	7.23e-06	2	94	2	24849370
Pubmed	Divide and conquer: an L-type voltage-gated calcium channel subtype finds a role in conditioned fear.	CACNA1C CACNA1D	7.23e-06	2	94	2	17015854
Pubmed	cDNA cloning and chromosomal mapping of a mouse gene with homology to NTPases.	ENTPD6 ENTPD5	7.23e-06	2	94	2	9457681
Pubmed	Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity.	NDOR1 SLC39A8	7.23e-06	2	94	2	28481222
Pubmed	Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area.	CACNA1C CACNA1D	7.23e-06	2	94	2	24848473
Pubmed	Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice.	RAG1 ST8SIA6	7.23e-06	2	94	2	35379746
Pubmed	UDP-N-acetylglucosamine transporter and UDP-galactose transporter form heterologous complexes in the Golgi membrane.	SLC35A3 SLC35A2	7.23e-06	2	94	2	23089177
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DNAJB12 HSP90B1 POGLUT3 SF3B1 NOMO2 VPS13A TYW1 SAMM50 MCCC2 PLXNB2 TP53BP1 ADD2 NOMO1 EFTUD2 MICU1	1.05e-05	1487	94	15	33957083
Pubmed	Sensory TRP channels contribute differentially to skin inflammation and persistent itch.	RAG1 TRPA1	2.16e-05	3	94	2	29081531
Pubmed	Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP).	CACNA1C CACNA1D	2.16e-05	3	94	2	17767505
Pubmed	Molecular architecture of the multiprotein splicing factor SF3b.	SF3B4 SF3B1	2.16e-05	3	94	2	12738865
Pubmed	Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes.	CACNA1C CACNA1D	2.16e-05	3	94	2	2173707
Pubmed	G protein-gated IKACh channels as therapeutic targets for treatment of sick sinus syndrome and heart block.	CACNA1C CACNA1D	2.16e-05	3	94	2	26831068
Pubmed	Truncation of murine CaV1.2 at Asp 1904 increases CaV1.3 expression in embryonic atrial cardiomyocytes.	CACNA1C CACNA1D	2.16e-05	3	94	2	23338940
Pubmed	Phosphorylation of TIP60 Suppresses 53BP1 Localization at DNA Damage Sites.	NDOR1 TP53BP1	2.16e-05	3	94	2	30297459
Pubmed	The intracellular II-III loops of Cav1.2 and Cav1.3 uncouple L-type voltage-gated Ca2+ channels from glucagon-like peptide-1 potentiation of insulin secretion in INS-1 cells via displacement from lipid rafts.	CACNA1C CACNA1D	2.16e-05	3	94	2	19351867
Pubmed	Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth.	CACNA1C CACNA1D	2.16e-05	3	94	2	21832054
Pubmed	Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels.	CACNA1C CACNA1D	2.16e-05	3	94	2	17289261
Pubmed	Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure.	CACNA1C CACNA1D	2.16e-05	3	94	2	23973784
Pubmed	MicroRNA-1976 regulates degeneration of the sinoatrial node by targeting Cav1.2 and Cav1.3 ion channels.	CACNA1C CACNA1D	2.16e-05	3	94	2	31302118
Pubmed	Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node.	CACNA1C CACNA1D	2.16e-05	3	94	2	23045342
Pubmed	Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.	CACNA1C CACNA1D	2.16e-05	3	94	2	24934288
Pubmed	Cancer-associated SF3B1-K700E mutation controls immune responses by regulating Treg function via aberrant Anapc13 splicing.	RAG1 SF3B1	2.16e-05	3	94	2	39303038
Pubmed	Chorein, the protein responsible for chorea-acanthocytosis, interacts with β-adducin and β-actin.	VPS13A ADD2	2.16e-05	3	94	2	24129186
Pubmed	An insight into the orphan nucleotide sugar transporter SLC35A4.	SLC35A3 SLC35A2	2.16e-05	3	94	2	28167211
Pubmed	VGLUT3 gates psychomotor effects induced by amphetamine.	SLC6A4 SLC17A8	2.16e-05	3	94	2	30556914
Pubmed	Genome-wide association study identifies five new schizophrenia loci.	CACNA1C CSMD1 ITIH4	3.26e-05	23	94	3	21926974
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	DNAJB12 PSEN2 NOMO2 VPS13A SAMM50 MCCC2 EXOC2 NOMO3 NOMO1	3.98e-05	606	94	9	36538041
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	HSP90B1 SF3B1 NOMO2 NARS1 NOMO3 TP53BP1 NOMO1	4.27e-05	344	94	7	30333137
Pubmed	HIF-1α Dependent Upregulation of ZIP8, ZIP14, and TRPA1 Modify Intracellular Zn2+ Accumulation in Inflammatory Synoviocytes.	TRPA1 SLC39A8	4.32e-05	4	94	2	34198528
Pubmed	IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis.	RAG1 NDOR1	4.32e-05	4	94	2	38019650
Pubmed	Beta-adrenergic-regulated phosphorylation of the skeletal muscle Ca(V)1.1 channel in the fight-or-flight response.	CACNA1C CACNA1D	4.32e-05	4	94	2	20937870
Pubmed	Cloning and mapping of a human and mouse gene with homology to ecto-ATPase genes.	ENTPD6 ENTPD5	4.32e-05	4	94	2	9271669
Pubmed	Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155.	SF3B4 SF3B1	4.32e-05	4	94	2	10490618
Pubmed	Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.	RAG1 NDOR1	4.32e-05	4	94	2	26371185
Pubmed	Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production.	RAG1 NDOR1	4.32e-05	4	94	2	20029045
Pubmed	X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C.	RAG1 ATP11C	4.32e-05	4	94	2	21518881
Pubmed	Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.	RAG1 NDOR1	4.32e-05	4	94	2	29136504
Pubmed	Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases.	RAG1 CYB561	4.32e-05	4	94	2	14499595
Pubmed	The CD39-like gene family: identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster.	ENTPD6 ENTPD5	4.32e-05	4	94	2	9676430
Pubmed	Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.	RAG1 NDOR1	4.32e-05	4	94	2	28196594
Pubmed	Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2.	CACNA1C CACNA1D	4.32e-05	4	94	2	17110593
Pubmed	NLRC4, ASC and Caspase-1 Are Inflammasome Components that Are Mediated by P2Y2R Activation in Breast Cancer Cells.	SLC7A10 NLRC4	4.32e-05	4	94	2	32397236
Pubmed	Sensitization of small-diameter sensory neurons is controlled by TRPV1 and TRPA1 association.	TRPA1 SLC17A8	4.32e-05	4	94	2	31914619
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HSP90B1 POGLUT3 SF3B1 NOMO2 APMAP PLXNB2 NOMO3 SIL1 NOMO1	4.35e-05	613	94	9	22268729
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	DNAJB12 HSP90B1 NOMO2 SLC35A2 ATP11C TYW1 SAMM50 GPR108 NOMO3 SIL1 NOMO1	5.32e-05	952	94	11	38569033
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	DNAJB12 HSP90B1 SF3B4 SF3B1 HSP90AB4P SPAG9 SAMM50 NOMO1 EFTUD2	5.92e-05	638	94	9	33239621
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	CACNA1C CACNA1D FRMD4A SAMM50 PLXNB2 PLEKHM1 SIL1	6.86e-05	371	94	7	15747579
Pubmed	Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels.	CACNA1C CACNA1D	7.19e-05	5	94	2	11296258
Pubmed	Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes.	RAG1 NDOR1	7.19e-05	5	94	2	29567770
Pubmed	Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.	CACNA1C CACNA1D	7.19e-05	5	94	2	15451373
Pubmed	Regulation of stress-induced sleep perturbations by dorsal raphe VGLUT3 neurons in male mice.	SLC6A4 SLC17A8	7.19e-05	5	94	2	38944834
Pubmed	Kv2.1 mediates spatial and functional coupling of L-type calcium channels and ryanodine receptors in mammalian neurons.	CACNA1C CACNA1D	7.19e-05	5	94	2	31663850
Pubmed	Cell-fate decisions in early T cell development: regulation by cytokine receptors and the pre-TCR.	RAG1 PSEN2	7.19e-05	5	94	2	9950750
Pubmed	MARCH1 protects the lipid raft and tetraspanin web from MHCII proteotoxicity in dendritic cells.	RAG1 NDOR1	7.19e-05	5	94	2	29371232
Pubmed	53BP1 facilitates long-range DNA end-joining during V(D)J recombination.	RAG1 TP53BP1	7.19e-05	5	94	2	18931658
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF711 DNAJB12 HSP90B1 SF3B4 SF3B1 MIA2 MGST3 APMAP ANTXR1 PLXNB2 TP53BP1 EFTUD2	9.73e-05	1203	94	12	29180619
Pubmed	An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.	NOMO2 NOMO3 NOMO1	9.84e-05	33	94	3	30783098
Pubmed	Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse.	CACNA1C CACNA1D	1.08e-04	6	94	2	16029198
Pubmed	Functional roles of a C-terminal signaling complex of CaV1 channels and A-kinase anchoring protein 15 in brain neurons.	CACNA1C CACNA1D	1.08e-04	6	94	2	21224388
Pubmed	UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats).	SLC35A3 SLC35A2	1.08e-04	6	94	2	25944901
Pubmed	Novel Foxo1-dependent transcriptional programs control T(reg) cell function.	RAG1 NDOR1	1.08e-04	6	94	2	23135404
Pubmed	Functional association of U2 snRNP with the ATP-independent spliceosomal complex E.	SF3B4 SF3B1	1.08e-04	6	94	2	10882114
Pubmed	L-type calcium channels play a critical role in maintaining lens transparency by regulating phosphorylation of aquaporin-0 and myosin light chain and expression of connexins.	CACNA1C CACNA1D	1.08e-04	6	94	2	23734214
Pubmed	Thalamus mediates neocortical Down state transition via GABAB-receptor-targeting interneurons.	SLC6A4 NECAB1	1.08e-04	6	94	2	34314698
Pubmed	Dysregulated lung stroma drives emphysema exacerbation by potentiating resident lymphocytes to suppress an epithelial stem cell reservoir.	HHIP NDOR1	1.08e-04	6	94	2	36822205
Interaction	NAAA interactions	DNAJB12 POGLUT3 MGST3 ENTPD6 EDEM2 ANTXR1 SAMM50 ITGB4 SIL1 NOMO1	6.47e-08	220	92	10	int:NAAA
Interaction	CBLN4 interactions	POGLUT3 PDGFRL ENTPD6 PLXNB2 NOMO3 SIL1 NOMO1	1.88e-06	127	92	7	int:CBLN4
Interaction	MPLKIP interactions	SF3B4 NDOR1 HSP90AB4P EFTUD2	2.14e-05	36	92	4	int:MPLKIP
Interaction	BRICD5 interactions	ENTPD6 GALNT5 PLXNB2 ITGB4 NOMO3 SIL1 NOMO1	3.02e-05	194	92	7	int:BRICD5
Interaction	EPHA10 interactions	DNAJB12 HSP90B1 POGLUT3 MIA2 NOMO3	4.62e-05	86	92	5	int:EPHA10
GeneFamily	Solute carriers	SLC6A4 SLC35A3 SLC35A2 SLC9A7 SLC17A8 SLCO3A1 SLC7A10 SLC39A8	2.75e-05	395	56	8	752
Coexpression	GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN	FRMD4A HSP90B1 POGLUT3 ST8SIA6 NARS1 SLCO3A1 NCMAP	7.92e-06	200	94	7	M9204
ToppCell	TCGA-Lung-Solid_Tissue_Normal\|TCGA-Lung / Sample_Type by Project: Shred V9	SLC6A4 GIMAP8 ST8SIA6 NECAB1 FREM3 NLRC4	1.43e-06	166	94	6	a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung\|TCGA-Lung / Sample_Type by Project: Shred V9	SLC6A4 GIMAP8 ST8SIA6 NECAB1 FREM3 NLRC4	1.43e-06	166	94	6	c64971c27cb445dffc5a636d4b6a60261b93a2db
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue\|TCGA-Lung / Sample_Type by Project: Shred V9	SLC6A4 GIMAP8 ST8SIA6 NECAB1 FREM3 NLRC4	1.43e-06	166	94	6	2f3072a7af048f184d33065fdd36153fd563155a
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6\|TCGA-Lung / Sample_Type by Project: Shred V9	SLC6A4 GIMAP8 ST8SIA6 NECAB1 FREM3 NLRC4	1.43e-06	166	94	6	188f2575511f418216874aed9118aa6f165252cb
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D HHIP PDGFRL FAT3 ITIH4	3.04e-06	189	94	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D PLPP1 FAT3 ANTXR1 ITIH4	3.13e-06	190	94	6	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	ST8SIA6 PLPP1 NOMO2 CSMD1 NOMO3 NOMO1	3.23e-06	191	94	6	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	Control-Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HSP90B1 FBH1 NOMO2 SLCO3A1 SIL1 NOMO1	3.23e-06	191	94	6	3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D PLPP1 FAT3 SLCO3A1 ANTXR1	3.33e-06	192	94	6	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D PLPP1 FAT3 SLCO3A1 ANTXR1	3.33e-06	192	94	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D PLPP1 FAT3 SLCO3A1 ANTXR1	3.53e-06	194	94	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D PLPP1 FAT3 SLCO3A1 ANTXR1	3.53e-06	194	94	6	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GIMAP8 ST8SIA6 SH3TC1 BTNL8 C8orf74 SLCO3A1	3.86e-06	197	94	6	31bec97c3952c48031bd66a5dad16a70a61519c3
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWC2 GIMAP8 ST8SIA6 PLPP1 ITGB4	2.56e-05	164	94	5	3cd80e6275f0f9b5667912139d15ebf5e6b17f2f
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SNX30 HHIP SPAG9 NCMAP SLC39A8	2.56e-05	164	94	5	b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SNX30 HHIP SPAG9 NCMAP SLC39A8	2.56e-05	164	94	5	3aea6207a011ad55a1aeb2ed9fb54d31b23694b5
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	VWC2 GIMAP8 ST8SIA6 CSMD1 ADD2	2.87e-05	168	94	5	8c3e1e45b422813bcdfa4273b1167db649a312f5
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GIMAP8 ST8SIA6 PLPP1 CSMD1 ITGB4	3.12e-05	171	94	5	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	moderate-Myeloid-Mast_cell\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWC2 HHIP ST8SIA6 GNPTAB HDC	3.49e-05	175	94	5	bbd2971bc6d69e507f90a637834d0936c205c590
ToppCell	facs-Marrow-T-cells-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A4 ST8SIA6 FAT3 UNC93A HDC	3.78e-05	178	94	5	41745a589567ca5ea6d06331f4c8da03595b5f5c
ToppCell	facs-Marrow-T-cells-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A4 ST8SIA6 FAT3 UNC93A HDC	3.78e-05	178	94	5	eb940dd64c973f68bcaad6069d3bd56383329db5
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SNX30 HHIP GALNT5 PLXNB2 SLC39A8	3.89e-05	179	94	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	FRMD4A PDGFRL GNPTAB TMEM74 ANTXR1	3.99e-05	180	94	5	886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NECAB1 ABCA13 FAT3 SLCO3A1 SLC39A8	4.10e-05	181	94	5	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWC2 HHIP ST8SIA6 PLPP1 HDC	4.10e-05	181	94	5	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NECAB1 ABCA13 SLCO3A1 SLC39A8 CRMP1	4.20e-05	182	94	5	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GIMAP8 ST8SIA6 PLPP1 CSMD1 ITGB4	4.54e-05	185	94	5	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HHIP PDGFRL FAT3 ANTXR1 ITIH4	4.91e-05	188	94	5	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	SF3B4 APMAP GNPTAB EXOC2 MICU1	5.03e-05	189	94	5	160963355256f7c0f2138da80c90de478f5a9fe8
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	GIMAP8 ST8SIA6 PLPP1 CSMD1 ITGB4	5.03e-05	189	94	5	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RAG1 KCNU1 GALNT5 ITGB4	5.12e-05	96	94	4	a48235df1f5526ce3ffc4c0c2ba038eb20229c55
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RAG1 KCNU1 GALNT5 ITGB4	5.12e-05	96	94	4	0fc179af7370a29b7bd5d81e1302a479ae72f196
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RAG1 KCNU1 GALNT5 ITGB4	5.12e-05	96	94	4	c301ecfd67ece8bb12be1b94b614957a58046457
ToppCell	Cerebellum-Macroglia-OLIGODENDROCYTE-O2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RAG1 KCNU1 GALNT5 ITGB4	5.12e-05	96	94	4	7d402d543ff159c9bb84c00b083e6e18fc0ff786
ToppCell	Fibroblasts-CD55+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	VWC2 HHIP VPS13A UGP2 ITIH4	5.16e-05	190	94	5	b4088128f5acf53f43244c9af9fe44e033f1a57a
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	B3GALT2 CACNA1D VWC2 PLPP1 FAT3	5.16e-05	190	94	5	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GIMAP8 ST8SIA6 PLPP1 CSMD1 ITGB4	5.16e-05	190	94	5	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 SLCO3A1 ANTXR1	5.29e-05	191	94	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GIMAP8 ST8SIA6 PLPP1 CSMD1 ITGB4	5.29e-05	191	94	5	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D HHIP FAT3 ITIH4	5.29e-05	191	94	5	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D HHIP PDGFRL ITIH4	5.29e-05	191	94	5	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	IPF-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	ST8SIA6 PLPP1 NOMO2 NOMO3 NOMO1	5.42e-05	192	94	5	e911e286da26202853f9650ba3cdefe5a5c9b585
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	SNX30 HHIP NECAB1 NCMAP SLC39A8	5.42e-05	192	94	5	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	ST8SIA6 NOMO2 CSMD1 NOMO3 NOMO1	5.42e-05	192	94	5	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 SLCO3A1 ANTXR1	5.42e-05	192	94	5	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SNX30 HHIP NECAB1 NCMAP SLC39A8	5.42e-05	192	94	5	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 SLCO3A1 ANTXR1	5.42e-05	192	94	5	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 SLCO3A1 ANTXR1	5.42e-05	192	94	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX30 HHIP NECAB1 NCMAP SLC39A8	5.56e-05	193	94	5	8646e573f2d2ff175f3d02bfdf214e65f3b614d3
ToppCell	Control-Fibroblasts-Vascular_smooth_muscle\|Control / group, cell type (main and fine annotations)	SLC6A4 CACNA1C GIMAP8 ST8SIA6 BTNL8	5.56e-05	193	94	5	60e44aac8be0430ad35e20eb98b1b700d76a0427
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D PLPP1 FAT3 ANTXR1	5.56e-05	193	94	5	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C CACNA1D FRMD4A FAT3 ANTXR1	5.69e-05	194	94	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VWC2 ST8SIA6 PLPP1 GNPTAB HDC	5.69e-05	194	94	5	aca009b9f1f320c0a65ea16df6595d7ede0b1fda
ToppCell	Control-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	SNX30 HHIP NECAB1 SPAG9 SLC39A8	5.69e-05	194	94	5	a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX30 HHIP NECAB1 NCMAP SLC39A8	5.83e-05	195	94	5	37aa6e4123d37de4de42ca68d3020f2a7686ce02
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1C NECAB1 FAT3 VPS13A CSMD1	5.83e-05	195	94	5	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX30 HHIP NECAB1 SPAG9 SLC39A8	5.98e-05	196	94	5	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	IPF-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	SLC6A4 ST8SIA6 BTNL8 ANTXR1 CRMP1	5.98e-05	196	94	5	8f0f72ead06abe02b575e443552eacc2151077ef
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1C CACNA1D PLPP1 FAT3 ANTXR1	6.12e-05	197	94	5	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	B_cells-Plasma_cells_and_plasmablasts\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	HSP90B1 FBH1 SLC39A8 SIL1 CYB561	6.12e-05	197	94	5	3b1c574b3d119b63967bb1306f0353ecc4c522f3
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HSP90B1 NOMO2 NOMO3 SIL1 NOMO1	6.12e-05	197	94	5	99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX30 HHIP NECAB1 SPAG9 SLC39A8	6.12e-05	197	94	5	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1C CACNA1D PLPP1 FAT3 ANTXR1	6.27e-05	198	94	5	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	NECAB1 FAT3 SLCO3A1 ADD2 CRMP1	6.27e-05	198	94	5	60d8d3bbd754ffde41c50013d822667b185a9751
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1C CACNA1D PLPP1 FAT3 ANTXR1	6.42e-05	199	94	5	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX30 HHIP NECAB1 SPAG9 SLC39A8	6.42e-05	199	94	5	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Biopsy_IPF-Epithelial-AT2\|Biopsy_IPF / Sample group, Lineage and Cell type	SNX30 HHIP NECAB1 NCMAP SLC39A8	6.42e-05	199	94	5	c841d475703d3489161fb7904526bd7563d5fb0f
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SNX30 HHIP TOB1 GALNT5 SLC39A8	6.58e-05	200	94	5	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	mLN-Dendritic_cell-cDC2\|Dendritic_cell / Region, Cell class and subclass	CEP104 PLEKHM1 SIL1 CYB561 MICU1	6.58e-05	200	94	5	e3f7852aaa26a9b3e626d85e40afde799e873045
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SNX30 HHIP NECAB1 NCMAP SLC39A8	6.58e-05	200	94	5	b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	KCNU1 TMEM74 SLC7A10 HDC	1.03e-04	115	94	4	9e65b4d30d498f2c415bfa9f5964fb72d2cb167d
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Airway\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC17A8 GALNT5 FREM3 SLC39A8	1.14e-04	118	94	4	8d96a4879b28979fa04fbaeffa271a6b9ecbe867
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	FRMD4A TOB1 UGP2 SLC39A8	1.34e-04	123	94	4	511b7c20a4a85e49980936d52af7dbca19bb848e
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	B3GALT2 ST8SIA6 GNPTAB HDC	1.97e-04	136	94	4	82d7f90ef2a63a3137c331efd68c036cd0db3ac1
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRPA1 SLC35A2 ITGB4 NCMAP	2.14e-04	139	94	4	505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCell	367C-Epithelial_cells-Epithelial-D_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SNX30 HHIP BTNL8 SLC39A8	2.26e-04	141	94	4	f3b1d757c4cac8596c542959c8f27f8bcaf3f513
ToppCell	367C-Epithelial_cells-Epithelial-D_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SNX30 HHIP BTNL8 SLC39A8	2.26e-04	141	94	4	bf68a54e755cda89fbc416636e522cd71d1e42d0
ToppCell	Control-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HSP90B1 FBH1 NOMO2 NOMO1	2.52e-04	145	94	4	fe68582f5a15b9714cb84fa32ac880e13cb69895
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TLK2 ATXN7L3B MYO1H ENTPD5	2.72e-04	148	94	4	10dcbdb47cac908648d9d652c8095b536db19b8a
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B0\|367C / Donor, Lineage, Cell class and subclass (all cells)	B3GALT2 SH3TC1 ATXN7L3B SLC35A2	2.80e-04	149	94	4	41f28138bde45d0b814e116837e5a32b5e80d54a
ToppCell	10x5'-bone_marrow-Lymphocytic_B-Pro-B\|bone_marrow / Manually curated celltypes from each tissue	RAG1 HHIP SH3TC1 CRMP1	3.17e-04	154	94	4	8a8c3851888ab86ca2b13ccc042cde1fef8d88f8
ToppCell	facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A4 FRMD4A FAT3 HDC	3.33e-04	156	94	4	da5cfa8fa9595613f04ce9511f8b42bad34d995a
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THOP1 NECAB1 ATP11C ADD2	3.41e-04	157	94	4	abfd05ed993b80822739f47a735f154092a23632
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A4 GIMAP8 PLPP1 BTNL8	3.58e-04	159	94	4	d3f81ba22160568ccaa6d2b04ebfd30630f9a6db
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TOB1 ABCA13 MYO1H PLXNB2	3.58e-04	159	94	4	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RAG1 APMAP GNPTAB ENTPD5	3.66e-04	160	94	4	955acb023ce4ccfac5073c9d693db87db3856187
ToppCell	NS-critical-d_16-33-Myeloid-Mast_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VWC2 HHIP ST8SIA6 HDC	3.66e-04	160	94	4	c61869d9dbba250270e59366e15af204e5b4395d
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C ABCA13 FAT3 UNC93A	3.84e-04	162	94	4	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Club-club-13\|World / Class top	SLC35A3 ST8SIA6 PDGFRL SLC9A7	3.84e-04	162	94	4	7d18f05a65ac715e62d610df9cc4a26539340dee
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST8SIA6 CSMD1 NCMAP CYB561	3.84e-04	162	94	4	80619a93c57fe16daf91dc571874ef9ac888953d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRMD4A C8orf74 SLCO3A1 ATP11C	4.02e-04	164	94	4	f6a961fa2002da7d9679f32af99e1314c0593ef9
ToppCell	NS-moderate-d_16-33-Myeloid-Mast_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	VWC2 HHIP ST8SIA6 HDC	4.02e-04	164	94	4	35c673380f75cb4bfe080089bc723c4373bcc7a5
ToppCell	facs-Marrow-B-cells-24m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLPP1 MGST3 NECAB1 ADD2	4.02e-04	164	94	4	18eeda51e69722992c3a7f699be293535a90868b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VWC2 ST8SIA6 GNPTAB HDC	4.02e-04	164	94	4	2c48c6e4eeee845f0563982d0bfa2a176ca5ef61
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGST3 SLC39A8 ADD2 CYB561	4.11e-04	165	94	4	436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCell	Club-club-12\|World / Class top	ST8SIA6 SLC7A10 SLC39A8 TRIM3	4.11e-04	165	94	4	9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGST3 SLC39A8 ADD2 CYB561	4.11e-04	165	94	4	242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCell	critical-Myeloid-Mast_cell\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWC2 HHIP ST8SIA6 HDC	4.11e-04	165	94	4	34a1cc6ccd46c059354e8fbde1ac69f202695a4e
ToppCell	moderate-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWC2 ST8SIA6 VPS13A HDC	4.21e-04	166	94	4	c3835b424c63bf11a4e2c47635dc3787fc4a637a
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENTPD5 MCCC2 SLC39A8 HDC	4.31e-04	167	94	4	ed7e785dcd25777f64e0c2596ada4f5a5ea17121
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1D	5.87e-05	4	93	2	DOID:0060173 (implicated_via_orthology)
Disease	Involutional paraphrenia	SLC6A4 CACNA1C FREM3	6.63e-05	25	93	3	C1571983
Disease	Psychosis, Involutional	SLC6A4 CACNA1C FREM3	6.63e-05	25	93	3	C1571984
Disease	Involutional Depression	SLC6A4 CACNA1C FREM3	6.63e-05	25	93	3	C0011574
Disease	N-acetylglucosaminylasparagine measurement	GNPTAB UNC93A	9.77e-05	5	93	2	EFO_0800151
Disease	brain volume measurement	HHIP MGST3 NUP210L FAT3 TMEM74 ENTPD6 EXOC2 PLEKHM1 SLC39A8	1.11e-04	595	93	9	EFO_0006930
Disease	Bipolar Disorder	SLC6A4 CACNA1C CACNA1D HSP90B1 PSEN2 ABCA13 CSMD1 ITIH4	1.35e-04	477	93	8	C0005586
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CACNA1C CACNA1D KCNU1	2.01e-04	36	93	3	DOID:11723 (implicated_via_orthology)
Disease	bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement	GNPTAB SLC39A8	2.04e-04	7	93	2	EFO_0802332
Disease	hepatocellular carcinoma (is_implicated_in)	SF3B4 SF3B1 PDGFRL SPAG9 EFTUD2	2.76e-04	181	93	5	DOID:684 (is_implicated_in)
Disease	neuroimaging measurement	SLC6A4 HHIP ST8SIA6 FAT3 ENTPD6 EXOC2 PLXNB2 SLC39A8 KLHL20 CRMP1 EFTUD2	5.42e-04	1069	93	11	EFO_0004346
Disease	insulin resistance	CACNA1D KCNU1 CSMD1	8.67e-04	59	93	3	EFO_0002614
Disease	cystatin-F measurement	APMAP ENTPD6	1.15e-03	16	93	2	EFO_0008104
Disease	theta wave measurement	FRMD4A SLC39A8	1.30e-03	17	93	2	EFO_0006873
Disease	triacylglycerol 48:1 measurement	SPAG9 CSMD1	1.30e-03	17	93	2	EFO_0010404
Disease	Manic Disorder	SLC6A4 CACNA1C CACNA1D	1.48e-03	71	93	3	C0024713
Disease	diet measurement, HOMA-B	FAT3 SLC39A8	1.62e-03	19	93	2	EFO_0004469, EFO_0008111
Disease	Colorectal Carcinoma	HHIP TTLL3 SH3TC1 PDGFRL ABCA13 VPS13A ATP11C HDC	1.70e-03	702	93	8	C0009402
Disease	Manic	SLC6A4 CACNA1C CACNA1D	1.94e-03	78	93	3	C0338831
Disease	Mood Disorders	SLC6A4 CACNA1C CACNA1D VPS13A	2.00e-03	168	93	4	C0525045
Disease	Depression, Bipolar	SLC6A4 CACNA1C CACNA1D	2.02e-03	79	93	3	C0005587
Disease	serum gamma-glutamyl transferase measurement	NUP210L NARS1 SLC9A7 SLC17A8 CSMD1 SLC39A8 TP53BP1 CYB561 MICU1	2.38e-03	914	93	9	EFO_0004532
Disease	Anhedonia	SLC6A4 CACNA1C	2.59e-03	24	93	2	C0178417
Disease	blood rubidium measurement	FRMD4A ABCA13	3.04e-03	26	93	2	EFO_0021529
Disease	psychosis predisposition measurement	CACNA1C CSMD1	3.04e-03	26	93	2	EFO_0008337

Protein segments in the cluster

Peptide	Gene	Start	Entry
DTLYESIIFAVGKGF	C8orf74	46	Q6P047
GGFDLYFILDKSGSV	ANTXR1	41	Q9H6X2
FAVSAQGFKALYEVL	CSMD1	126	Q96PZ7
FYLEFAETGSVKDFG	ATXN7L3B	46	Q96GX2
KIGVFLDYECGTISF	BTNL8	406	Q6UX41
AVAVTFGEKLLGYFS	SLC7A10	301	Q9NS82
FAFLFKTAEVLGGIS	ABCA13	1011	Q86UQ4
GTLFVADAYKGLFEV	APMAP	161	Q9HDC9
EALLFNLGGKYSAFE	CYB561	181	P49447
GFGFDVSYAFLEKLA	ITIH4	416	Q14624
FKFIFRGTGYDEKLV	RAG1	701	P15918
TIGDFKAYALAGVSF	NOMO3	866	P69849
VVGASVFYKDVAGLD	SPAG9	706	O60271
FRGFLKGIEYADSFT	HDC	286	P19113
TIGDFKAYALAGVSF	NOMO2	866	Q5JPE7
SYITALLKDGFGFAD	ENTPD5	381	O75356
EFKAFYGDTLVTGFA	MCCC2	346	Q9HCC0
ASALDFIKLDFYGGA	NLRC4	606	Q9NPP4
FSFAEVAKRGVEGAY	GNPTAB	566	Q3T906
GVGFYSAYLVAEKVA	HSP90AB4P	106	Q58FF6
GVDSYFEYLVKGAIL	EDEM2	256	Q9BV94
EKFADEGSIFYTLGE	MICU1	186	Q9BPX6
RLFYEDGSGEKSFVA	PLXNB2	131	O15031
SLAYVKGGLSTFFEA	EXOC2	201	Q96KP1
TIGDFKAYALAGVSF	NOMO1	866	Q15155
AIEYKSLFTDGFCGL	KCNU1	556	A8MYU2
KEYGFVLLTGAASFI	MGST3	6	O14880
DYTIGFGKFVDKVSV	ITGB4	166	P16144
GEDFLYKSSGAIVAA	NCMAP	21	Q5T1S8
DFAVLGLGDSSYAKF	NDOR1	91	Q9UHB4
GVGFYSAFLVADKVI	HSP90B1	196	P14625
GYVFSGDLAEKIFKV	B3GALT2	316	O43825
KEKEYFGIAFTDETG	FRMD4A	56	Q9P2Q2
YKTIFEGFAKIDGRA	CEP104	661	O60308
EGFSGFKRYVTAAED	FBH1	816	Q8NFZ0
GFDGTTYLKTIEVFD	KLHL20	561	Q9Y2M5
AGDDEVTVGKFYATF	CACNA1C	1656	Q13936
AGGLFSIDKSYFFEL	GALNT5	671	Q7Z7M9
GATEAFKAIGTAYAV	DNAJB12	146	Q9NXW2
ISYSIVDGNDDGKFF	FAT3	1291	Q8TDW7
AKLEAIFGADFTKYA	GIMAP8	546	Q8ND71
IELGFFVEEYAGSKG	HELQ	406	Q8TDG4
AGYTGGDVSFIKEDF	SAMM50	286	Q9Y512
AGDDEVTVGKFYATF	CACNA1D	1596	Q01668
LYEAFTFLKGLGAVI	CRMP1	181	Q14194
KETFSLVEGSGYFLV	NUP210L	916	Q5VU65
GFAILGFAYAKEDKI	MIA2	381	Q96PC5
KVFVGESFIVYEGEK	FREM3	1071	P0C091
GVYEGFLKALIEFAS	PLEKHM1	971	Q9Y4G2
VFTADFGLTSEYGLK	MEIOC	411	A2RUB1
EIAVVAGFAAFLGKY	SLCO3A1	361	Q9UIG8
GATLFKLDYFGEEAF	NARS1	281	O43776
GSLVVGDFEIAAKYV	ENTPD6	401	O75354
VEGSTLAFFVLTGYK	GPR108	481	Q9NPR9
ATIYKAIGTFLFGAA	PLPP1	96	O14494
LVKEYAAFVLGAAFS	SIL1	241	Q9H173
KALFLEDIATYGDAF	ST8SIA6	251	P61647
EGSFGDLFLVVAVYA	SH3TC1	591	Q8TE82
GSTYIFFTEKGELFV	PDGFRL	161	Q15198
LLAVALGFFEGDAKF	HHIP	11	Q96QV1
LSSGFAGVYFEKILK	SLC35A2	211	P78381
GGFSEVYKAFDLTEQ	TLK2	471	Q86UE8
GVVALGDTVEEAFYK	ADD2	291	P35612
EIALVKGAKRYGFTF	ATP11C	501	Q8NB49
LDAGITGYFFFQEKE	POGLUT3	336	Q7Z4H8
LDTFIGEGKEYIFVS	UGP2	236	Q16851
VDESGFVYAIGEKFA	VWC2	156	Q2TAL6
LVFLSSIFGYCKEAG	TRPA1	776	O75762
LGEKTIYLVSFFEGL	VPS13A	2481	Q96RL7
EFAAIGDYLDTFALK	SNX30	241	Q5VWJ9
GVLKSLSFLFEYIGE	SF3B1	1146	O75533
LYGVLFEKSKEAAFA	UNC93A	371	Q86WB7
DFIFYSVLVGKAAAT	PSEN2	366	P49810
GELYDEKADVFAFGI	TESK1	231	Q15569
ALSEDEYFSAGVVKG	TP53BP1	1546	Q12888
RKASFELYGADFVFG	TTLL3	446	Q9Y4R7
LIAGFYEDVSAVAKG	PIGN	101	O95427
AFDVFAAYGGLNEKS	TOB1	306	P50616
GSLSKYAEDIFGELF	WASF2	41	Q9Y6W5
SGFAGVYFEKILKET	SLC35A3	186	Q9Y2D2
VEKAVAVFGGFYLLF	SLC39A8	196	Q9C0K1
GLEVSGFGEIKYEEF	ZNF875	236	P10072
EKDIFVSGVKIFYGS	TYW1	71	Q9NV66
GKSIDYGFISAILFL	TMEM74	171	Q96NL1
GSFAKIYADTFGDIN	EFTUD2	321	Q15029
DAAAFFKSVGIFLGI	SLC9A7	316	Q96T83
EDGFGSEVIKVYIFK	ZNF711	236	Q9Y462
LTFGGAYVVKLLEEY	SLC6A4	481	P31645
DAASGEVVGKFYLDL	THOP1	401	P52888
IDEKLLYDTFSAFGV	SF3B4	111	Q15427
VKVYSADGEFLFKFG	TRIM3	646	O75382
FEEVFGFAISKVGLL	SLC17A8	341	Q8NDX2
VIGLLDIYGFEVFDK	MYO1H	386	Q8N1T3
LSFEEFKAYFADGVL	NECAB1	46	Q8N987
FKAYFADGVLSGEEL	NECAB1	51	Q8N987